The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of plasma adiponectin with tumor infiltrating lymphocytes and survival in patients with stage III colon cancer (NCCTG N0147; Alliance).
 
Frank A. Sinicrope
Stock and Other Ownership Interests - illumina
Honoraria - American Society of Clinical Oncology; Imedex
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); HalioDx (Inst); Roche (Inst); Ventana Medical Systems (Inst)
Research Funding - Ventana Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Patent royalty related to immune markers in colon cancer. Patent jointly held between myself and Roche/Ventana Medical Systems. (Inst)
Travel, Accommodations, Expenses - ventana medical systems
 
Qian Shi
Stock and Other Ownership Interests - Amgen; Johnson & Johnson; Merck
Consulting or Advisory Role - Boehringer Ingelheim; Yiviva
Research Funding - Celgene (Inst); Roche/Genentech (Inst)
 
Thomas C. Smyrk
No Relationships to Disclose
 
Richard M. Goldberg
Stock and Other Ownership Interests - Advanced Chemotherapy Technologies
Honoraria - Amgen
Consulting or Advisory Role - AstraZeneca; Bayer; Merck; Novartis; Taiho Pharmaceutical
Expert Testimony - Genentech/Roche; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; Merck; Merck KGaA
 
Steven J. Cohen
No Relationships to Disclose
 
Sharlene Gill
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Ipsen; Roche Canada; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical (Inst)
 
Morton S. Kahlenberg
Employment - Tenet Healthcare
Consulting or Advisory Role - Genentech
Speakers' Bureau - Genentech
Travel, Accommodations, Expenses - Genentech/Roche
 
Suresh Nair
Stock and Other Ownership Interests - Biontech; Gilead Sciences; Moderna Therapeutics; Novavax
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Nektar (Inst)
 
Anthony Frank Shields
Consulting or Advisory Role - Caris Life Sciences; ImaginAb
Speakers' Bureau - Caris Life Sciences
Research Funding - Alkermes; Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Biomedical; Caris Life Sciences; Daiichi Sankyo; Eisai; Esperas Pharma; Esperas Pharma; Exelixis; Five Prime Therapeutics; H3 Biomedicine; Halozyme; Hutchison China Meditech; ImaginAb; Incyte; Inovio Pharmaceuticals; Jiangsu Alphamab Biopharmaceuticals; Lexicon; LSK BioPharma; MSK Pharma; Nouscom; Plexxikon; Repertoire Immune Medicines; Seagen; Shanghai HaiHe Pharmaceutical; Taiho Pharmaceutical; Telix Pharmaceuticals; Xencor
Travel, Accommodations, Expenses - Caris Life Sciences; GE Healthcare; ImaginAb; Inovio Pharmaceuticals; TransTarget
 
Balkrishna N. Jahagirdar
No Relationships to Disclose
 
Sawyer B. Jacobson
No Relationships to Disclose
 
Nathan R. Foster
No Relationships to Disclose
 
Michael N. Pollak
No Relationships to Disclose
 
Steven R Alberts
No Relationships to Disclose